Autoimmune Pitfalls of Anti-Tumor Necrosis Factor-Alpha Therapy

Isr Med Assoc J. 2015 Feb;17(2):117-9.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Autoantibodies / blood
  • Autoimmunity / drug effects
  • Etanercept
  • Humans
  • Immunoglobulin G* / administration & dosage
  • Immunoglobulin G* / adverse effects
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Lupus Erythematosus, Systemic* / chemically induced
  • Lupus Erythematosus, Systemic* / diagnosis
  • Lupus Erythematosus, Systemic* / immunology
  • Lupus Erythematosus, Systemic* / physiopathology
  • Lupus Erythematosus, Systemic* / therapy
  • Male
  • Middle Aged
  • Prednisone / administration & dosage*
  • Receptors, Tumor Necrosis Factor* / administration & dosage
  • Recombinant Fusion Proteins / administration & dosage
  • Recombinant Fusion Proteins / adverse effects
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Withholding Treatment

Substances

  • Autoantibodies
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Recombinant Fusion Proteins
  • Tumor Necrosis Factor-alpha
  • Etanercept
  • Prednisone